OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Gevorg Tamamyan: The Day We Decided War Will No Longer Mean the End of Cancer Care

Highlights From How I Treat Bladder Cancer in 2026: OncoDaily Virtual Summit

Yvonne Awards 2026

Grand Rounds by OncoDaily: AI in Oncology Edition

Dario Trapani: Launching WHO Academy Webinar Series on National Cancer Control Planning

OncoDaily Brings Sarcoma Experts Together at ASCO 2026

Helena Kremer: Brazilian Government Announces R$1.1 Billion Oncology Complex Integrated With INCA In Rio

King Hussein Cancer Research Award: Advancing Cancer Research Across the Arab World 2026

Calculators

Body Mass Index (BMI)

Cockcroft-Gault Creatinine Clearance Calculator

BSA Calculator – Body Surface Area

Carboplatin Dose Calculator (Calvert Formula)

Child-Pugh Score Calculator

ECOG Score Calculator

IBW / Adjusted Body Weight (Devine Formula)

Bone Scan Index (BSI) Tracker

Khorana Score (Cancer-Associated VTE Risk)

MASCC Risk Index Calculator (Febrile Neutropenia)

IMDC Risk Score Calculator (Metastatic RCC)

Oncotype DX Recurrence Score (RS) Categorizer

Cisplatin Cumulative Dose Toxicity Tracker

CTCAE v6.0 Adverse Events Grader

Grade adverse events based on CTCAE v6.0 criteria. Select an adverse event and enter the lab value or clinical finding to determine the severity grade (1-5).

Enter the lab value or clinical finding

CTCAE v6.0 Grade Scale:

  • Grade 1: Mild; asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated.
  • Grade 2: Moderate; minimal, local or noninvasive intervention indicated; limiting instrumental ADL.
  • Grade 3: Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of hospitalization indicated.
  • Grade 4: Life-threatening consequences; urgent intervention indicated.
  • Grade 5: Death related to AE.